Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...
Hosted on MSN
Canada approves second generic Ozempic within days
Health Canada has approved a second generic version of semaglutide, the active ingredient in Ozempic, shortly after authorizing the first. The latest approval, for Toronto-based Apotex, makes Canada ...
Health Canada has approved a second generic version of semaglutide, the active ingredient in Ozempic, Wegovy and Mounjaro, from Canadian firm Apotex. This follows the country’s first generic approval ...
This article provides an overview of the regulatory regime and associated intellectual property rights for veterinary drug ...
The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal ...
For the past 15 years, Gerald W. Smetana, MD, MACP, from Harvard Medical School, has given a presentation at the ACP Internal ...
The FDA has issued a series of regulatory updates in recent weeks spanning gene therapy, drug approvals, clinical trial oversight and compounding policy, reflecting a broader push to accelerate ...
Eli Lilly's market share in India's weight‑loss drug market fell to 56% in March from 61% in February. Novo Nordisk's market share remained steady at 25%. Indian generic drugmakers have launched 26 ...
MIRAMAR, Fla., April 9, 2026 /PRNewswire/ -- DifGen Pharmaceuticals LLC, a U.S.-based specialty generic pharmaceutical company today announced that its partner, Apotex Inc., has received final ...
Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established cardiovascular disease or multiple risk factors, and to improve glycemic control ...
To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Nearly half of U.S. generic prescriptions originate in India, which relies on the Strait of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results